Qualigen Therapeutics (QLGN) Institutional Ownership $3.85 +0.03 (+0.79%) As of 11:38 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Qualigen Therapeutics (NASDAQ:QLGN)CurrentInstitutional OwnershipPercentage3.18%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$27.47KNumber ofInstitutional Sellers(last 12 months)0 Get QLGN Insider Trade Alerts Want to know when executives and insiders are buying or selling Qualigen Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data QLGN Institutional Buying and Selling by Quarter Qualigen Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/17/2025 FNY Investment Advisers LLC7,548$27K0.0%N/A1.026% 8/10/2023 Meitav Investment House Ltd.27,293$3.21M0.0%N/A0.540% 7/24/2023 Meitav Investment House Ltd.27,293$3.21M0.1%N/A0.540% 5/10/2022 Ground Swell Capital LLC43,251$29K0.1%N/A0.123% 1/31/2022 Commonwealth Equity Services LLC87,510$93K0.0%-36.4%0.298% 11/15/2021 Franklin Resources Inc.82,000$107K0.0%N/A0.283% 11/15/2021 GSA Capital Partners LLP78,687$102K0.0%N/A0.271% 10/14/2021Hatton Consulting Inc.27,195$35K0.0%-26.9%0.094% 8/16/2021 State Street Corp104,314$208K0.0%N/A0.362% 8/13/2021 Renaissance Technologies LLC113,911$227K0.0%N/A0.395% 8/13/2021 Geode Capital Management LLC168,702$335K0.0%+10.3%0.585% 8/13/2021 Vanguard Group Inc.1,023,911$2.04M0.0%+239.9%3.551% 8/11/2021 Commonwealth Equity Services LLC137,510$273K0.0%+10.9%0.477% 8/2/2021Hatton Consulting Inc.37,195$74K0.1%-35.0%0.129% 6/23/2021 StoneX Group Inc.13,442$36K0.0%N/A0.047% 5/17/2021 Price T Rowe Associates Inc. MD107,500$290K0.0%N/A0.373% 5/12/2021 Geode Capital Management LLC152,898$412K0.0%+24.3%0.530% 5/11/2021 Vontobel Holding Ltd.25,300$68K0.0%N/A0.088% (Data available from 1/1/2016 forward) QLGN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of QLGN shares? During the previous two years, the following institutional investors and hedge funds held shares of Qualigen Therapeutics shares: Meitav Investment House Ltd. ($3.21M), FNY Investment Advisers LLC ($27K).Learn more on QLGN's institutional investors. What percentage of Qualigen Therapeutics stock is owned by institutional investors? 3.18% of Qualigen Therapeutics stock is owned by institutional investors. Learn more on QLGN's institutional investor holdings. Which institutional investors have been buying Qualigen Therapeutics stock? The following institutional investors have purchased Qualigen Therapeutics stock in the last 24 months: Meitav Investment House Ltd. ($54.59K), and FNY Investment Advisers LLC ($7.55K). How much institutional buying is happening at Qualigen Therapeutics? Institutional investors have bought a total of 62,134 shares in the last 24 months. This purchase volume represents approximately $2.51M in transactions. Related Companies TLPH Institutional Ownership ADXN Institutional Ownership CLDI Institutional Ownership APRE Institutional Ownership CYCN Institutional Ownership NLSP Institutional Ownership KPRX Institutional Ownership AEON Institutional Ownership BCLI Institutional Ownership CARM Institutional Ownership This page (NASDAQ:QLGN) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qualigen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Qualigen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy QLGN Stock Free QLGN Stock Alerts